SSKN

0.00010.00%
SR

Shmuel Rubinstein

Independent Director

Mr. Shmuel Rubinstein, also known as Milky, Samuel, is Director of Keystone Dental, Inc. He is Director of MediWound Ltd. from August 2023. Mr. Rubinstein has been Director of Exalenz Bioscience Ltd. since September 11, 2007. He has served as the Senior Vice President and General Manager of Taro Pharmaceuticals Industries and has experienced all health authorities inspection. Mr. Rubinstein served as Director at Kamada Ltd. since December 2017 until December 24, 2019. On 2003, Mr. Rubinstein received the Exceptional Industrialist award. Mr. Rubinstein serves as Board Member in Exalenz, Medison Biotech, Trima Pharma, Keystone Dental, Kamada Ltd. and as consultant to BDO and Sol-Gel Pharma. Mr. Rubinstein served as External Independent Director at Clal Biotechnology Industries Ltd until 2020. Mr. Rubinstein is also a Director at the Medical Research Fund Nearnear The Tel Aviv Sourasky Medical Center and The National Authority for Yiddish Culture. Mr. Rubinstein has been an Independent Director of STRATA Skin Sciences, Inc. since May 29, 2018. He is Director at KSDG. He served as a Director Sol-Gel Technologies Ltd. Mr. Rubinstein serves on several public and private companies as a consultant to some start ups and mature companies. He also finished an International Marketing Course at the Wharton School of the University of Pennsylvania.

Positions